Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months

Response to tyrosine kinase inhibitors at three months is a predictor for long-term outcome in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. We analyzed 456 newly diagnosed chronic myeloid leukemia patients treated with tyrosine kinase inhibitors to determine their outco...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nazha, Aziz, Kantarjian, Hagop, Jain, Preetesh, Romo, Carlos, Jabbour, Elias, Quintas-Cardama, Alfonso, Luthra, Raja, Abruzzo, Lynne, Borthakur, Gautam, Ravandi, Farhad, Pierce, Sherry, O’Brien, Susan, Cortes, Jorge
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2013
Témata:
Chronic Myeloid Leukemia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815167/
https://ncbi.nlm.nih.gov/pubmed/23812943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.090282
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky